潜江永安药业完成子公司股权收购工商变更登记

Core Viewpoint - The company plans to acquire 49.20% equity of its subsidiary, Hubei Ling'an Technology Co., Ltd., for 27 million yuan, resulting in 100% ownership after the transaction is completed [1] Group 1 - The acquisition will be funded using the company's own funds [1] - Following the acquisition, the consolidation scope of financial statements will remain unchanged [1] - Hubei Ling'an Technology has completed the necessary business registration changes, with the legal representative changing from Zhang Yong to Chen Yong [1] Group 2 - The company has already paid the first installment of the acquisition price, with subsequent payments to follow [1] - The new business license clarifies the company's basic information and business scope [1] - Investors are reminded to pay attention to risks associated with the transaction [1]